bibliographic resource 75763 [br/75763]
https://w3id.org/oc/corpus/br/75763
- is a
-
- title
-
- Elotuzumab in combination with lenalidomide and dexamethasone in patients with relapsed multiple myeloma: final phase 2 results from the randomised, open-label, phase 1bâ2 dose-escalation study
- publication date
-
- contributor
-
- format
-
- identifier
-
- part of
-